$TRAW

$0.37 +$0.02 (7.3%) Close

$TRAW Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 15.4M shares outstanding

Who owns TRAW?

By type of holder

Institutions 40.1% Insiders 12.4% Everyone else 47.5%

Concentration Top 10 holders own 45.8%

OrbiMed Capital GP VIII LLC 12.2% · Orbimed Advisors LLC 7.8%

Institutional ownership

40.1%

+16.5 pts vs last qtr

Institutional holders

+5 vs last qtr

Net shares bought

+2.5M

by institutions in Q2 2026

New / sold out

12 / 7

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Ally Bridge Group (NY) LLC NEW +786.2K
Orbimed Advisors LLC +597.7K

Biggest sellers in Q2 2026

Squadron Capital Management LLC SOLD OUT −511.7K
Dauntless Investment Group, LLC −336.4K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Traws Pharma Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2023–FY2025

+897.7%

+215.87% a year

Each share's claim on the business

−90.0%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $3.42M

over 3 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years47% Under 1 year53%

Quarterly turnover

68.0%

of institutional shares changed hands

Top 10 managers, median time held

2 quarters

Super Investors

Investment managers reporting TRAW on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
OA Orbimed Advisors LLC 13D · 11.9%	1.2M	7.83%	+597.7K (+98.7%)	2024	0.0%
Shares held by quarter Peak holding1.2M (Q2'26) Change over 8 quarters+597.7K Share of the company7.830% Disclosed stake13D · 11.9% Orbimed Advisors LLC's full portfolio →
AB Ally Bridge Group (NY) LLC	786.2K	5.12%	NEW	Q2 '26	0.6%
Shares held by quarter Peak holding786.2K (Q2'26) Change over 8 quarters+786.2K Share of the company5.120% Ally Bridge Group (NY) LLC's full portfolio →

Orbimed Advisors LLC

13D · 11.9%

1.2M

% of company

7.83%

Change vs last qtr

+597.7K (+98.7%)

Held since

2024

Ally Bridge Group (NY) LLC

786.2K

% of company

5.12%

Change vs last qtr

NEW

Held since

Q2 '26

28 more super investors behind a free account

See every manager holding Traws Pharma Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting TRAW on Form N-PORT; together they hold 2.8% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$149K	177.2K	1.15%	0.00%	June 30, 2026
VE Vanguard Extended Market Index Fund Vanguard Index Funds	$129K	152.8K	0.99%	0.00%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$149K

% of company

1.15%

% of the fund

0.00%

As of

June 30, 2026

Vanguard Extended Market Index Fund

Vanguard Index Funds

Position value

$129K

% of company

0.99%

% of the fund

0.00%

As of

June 30, 2026

5 more funds behind a free account

See every fund holding Traws Pharma Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
OC OrbiMed Capital GP VIII LLC 5%+ holder 13D · 11.9%	1.9M	12.21%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company12.210% Disclosed stake13D · 11.9% View the 13D/G filing →
DI Dukes Iain D. Insider	171.1K	1.11%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company1.110% Dukes Iain D.'s insider activity →

OrbiMed Capital GP VIII LLC

5%+ holder13D · 11.9%

1.9M

% of company

12.21%

Change vs last qtr

—

Held since

—

Dukes Iain D.

Insider

171.1K

% of company

1.11%

Change vs last qtr

—

Held since

—

9 more holders behind a free account

See every insider and 5%+ holder of Traws Pharma Inc.

Comments